Pages that link to "Q59265089"

The following pages link to Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer (Q59265089):

Displaying 42 items.

• RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant (Q21090538) (← links)
• Diverse functions of RNase L and implications in pathology (Q24652347) (← links)
• A scientific journey through the 2-5A/RNase L system (Q24679551) (← links)
• A new human retrovirus associated with prostate cancer (Q27478010) (← links)
• Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer (Q33346247) (← links)
• Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells (Q33561543) (← links)
• Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases (Q33898895) (← links)
• Molecular genetics of prostate cancer: new prospects for old challenges (Q34127462) (← links)
• Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China (Q34443672) (← links)
• Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer (Q34804987) (← links)
• Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study (Q35089535) (← links)
• 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer (Q35199341) (← links)
• Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells (Q35545869) (← links)
• XMRV Discovery and Prostate Cancer-Related Research (Q35692335) (← links)
• Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population (Q36113139) (← links)
• Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses (Q36250391) (← links)
• Inflammation in prostate carcinogenesis (Q36554784) (← links)
• Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention (Q36684362) (← links)
• RNase L is a negative regulator of cell migration (Q36688975) (← links)
• A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer (Q36699077) (← links)
• Genetic variability in inflammation pathways and prostate cancer risk (Q36812689) (← links)
• Germline genetic profiling in prostate cancer: latest developments and potential clinical applications. (Q37474516) (← links)
• RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells (Q37729091) (← links)
• The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. (Q37762153) (← links)
• Genetic analysis of the principal genes related to prostate cancer: a review (Q38058970) (← links)
• The genetic epidemiology of prostate cancer and its clinical implications (Q38168060) (← links)
• An update analysis of two polymorphisms in encoding ribonuclease L gene and prostate cancer risk: involving 13,372 cases and 11,953 controls (Q38770707) (← links)
• New advances in our understanding of the "unique" RNase L in host pathogen interaction and immune signaling (Q38946458) (← links)
• Prostate Cancer Genetics: A Review (Q38967495) (← links)
• Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL. (Q38978320) (← links)
• Biology and pathophysiology of the new human retrovirus XMRV and its association with human disease (Q39846646) (← links)
• Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer. (Q40991532) (← links)
• Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis (Q41161926) (← links)
• RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis (Q44895615) (← links)
• Association of a common genetic variant in RNASEL and prostate cancer susceptibility (Q46949052) (← links)
• The RNASEL -1385G/A polymorphism is associated with risk of prostate cancer in Africans (Q47661684) (← links)
• Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities. (Q52566012) (← links)
• Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer (Q56774624) (← links)
• The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel (Q80194693) (← links)
• Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study (Q80960675) (← links)
• Prostate cancer (Q81295804) (← links)
• RNASEL −1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case–control studies (Q83164417) (← links)